In this episode, Boston Scientific Chair, CEO and President Mike Mahoney discusses his journey in the medical device industry, the qualities that make a great leader, and the strategies that have fueled the company's growth.
 
Inspired by his grandfather, a cardiac surgeon, Mahoney initially wanted to become a doctor but ended up pursuing a career in business. Mahoney saw an opportunity at Boston Scientific when the company was struggling. Despite the risks involved, he took on the role of CEO because he believed in his skills and had a long-term vision for the company.
 
Through the efforts of the company's leaders, a strong supply chain team, efficient operations, and a robust innovation pipeline, Boston Scientific has managed to maintain a 14% growth rate in a challenging market environment.
 
Mahoney also highlights the company's focus on interventional medicine, which allows for quick procedures and same-day patient discharges, reducing the burden on hospitals. Mahoney further discusses the company's urology division, which has grown from a $500 million business to a $2 billion business. This growth has been fueled by a combination of organic R&D and acquisitions, creating a wide portfolio of differentiated products. Mahoney further elaborates on the company's diverse portfolio, mentioning the success of their peripheral vascular business and the potential of their diagnostics portfolio.
 
Tune in to this episode for more on Mahoney’s strategies, challenges, and opportunities, offering valuable insights into the company's approach to driving growth and innovation in the medical device industry.

Thank you to Resonant Link for sponsoring this episode of Boston Scientific Talks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the Boston Scientific Talks Podcast.

Subscribe to this podcast on every major podcast platform.

Boston Scientific CEO Mike Mahoney on leadership, growth, innovation, and career-changing gut checks

This week we’ll visit with Daniel Hawkins, CEO of Avail Medsystems. Hawkins is a prolific and successful medtech entrepreneur who was an early employee at Intuitive and co-founder of Shockwave Medical. Hawkins talks about both experiences, but DeviceTalks listeners should listen carefully for his insights on how ASCs are changing medtech and how OEMs are using Avail’s telepresence system to compensate.

DeviceTalks Editorial Director Tom Salemi and Managing Editor Kayleen Brown share their takeways from the MedtechVISION conference in Menlo Park. The conference raised many themes that we’ll be exploring at DeviceTalks West on October 18-19 at the Santa Clara Convention Center.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on many major podcast player.

Hawkins on how Avail is changing Medtech; Turning Pain into Purpose & other MedtechVision Takeaways

In this special episode of IntuitiveTalks, recorded live from DeviceTalks West, Dave Rosa, President of Intuitive, shares the experience of the company's pioneering role in surgical robotics. Rosa reflects on the initial skepticism faced by the company and the subsequent validation of their work as the industry has grown to embrace robotic assistance in surgery. He also discusses the balance between innovation and the practicalities of scaling a business, emphasizing the importance of reliability and supply chain management in healthcare technology.

Rosa also addresses the future of surgical robotics, hinting at a shift towards more compact and specialized devices that could transform patient care. He highlights the economic benefits of robotic surgery, particularly its potential to reduce the overall costs of healthcare while improving surgical outcomes.

A must for all medtech stakeholders, this episode offers a thoughtful perspective on leading a company at the forefront of medical technology. Rosa's conversation is a blend of personal experience and professional insights, providing valuable lessons on growth, adaptation, and the continuous effort to improve surgical care.

Thanks to maxon Group for sponsoring this episode. Visit https://www.maxongroup.us/maxon/view/content/medical to learn more about how maxon Group works with medical device companies.

Thank you for listening to the IntuitiveTalks Podcast.

Subscribe to this podcast on every major podcast platform.

Intuitive's Dave Rosa shares insights on surgical robotics’ evolution, offers advice to new players

In this episode of StrykerTalks, neurovascular president Jim Marucci discusses the company's latest advancements in neurovascular technology and how that, and its expanding global footprint, are shaping the future of its neurovascular division.

Marucci details the company's recent strategic acquisition of Cerus Endovascular, which has increased Stryker's capabilities in treating wide-neck bifurcated aneurysms. Furthering Stryker's goal to simplify procedures, reduce costs, and improve patient outcomes.

The conversation also touches on developing new products like the Target Tetra detachable coil for smaller aneurysms and the potential of emerging technologies like AI, AR, and VR in neurovascular procedures. Marucci anticipates these technologies will play a crucial role in advancing the field and improving access to care globally.

Tune in for a comprehensive overview of Stryker's current strategies, product innovations, and future directions in the neurovascular sector, underlining its commitment to enhancing stroke care and neurovascular treatments worldwide.

Thank you to Zeus for sponsoring this episode. To learn more about how Zeus works with medical device companies, visit www.zeusinc.com. 

Thank you for listening to the StrykerTalks Podcast.

Subscribe to this podcast on every major podcast platform.

Stryker’s neurovascular president Jim Marucci on Cerus acquisition, Target Tetra and AI/AR potential

In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses. 

In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office.

Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth. 

Thank you to our season one sponsors, AcuityMD and Millstone Medical for supporting this podcast. To learn more about our episode sponsor, AcuityMD, please visit http://acuitymd.com.

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A

This episode of Boston Scientific Talks features Boston Scientific's entrance into advanced endoluminal surgery and obesity management, spearheaded by its acquisition of Apollo Endosurgery in November 2022. 

Chief Medical Officer, Endoscopy Brian Dunkin, MD and SVP and President, Endoscopy Mike Jones explore the strategic value of this acquisition and the integration of Apollo's technology, which is poised to potentially revolutionize endoscopic procedures.

The discussion centers on the potential of Apollo's technology in broadening Boston Scientific's endoluminal surgery capabilities. Jones highlights the addition of the Overstitch device, which enhances the company's ability to perform endoscopic suturing and endoluminal sleeve gastroplasty, addressing obesity through minimally invasive means. Additionally, Dr. Dunkin provides a clinical perspective on how these technologies represent a paradigm shift in surgery, moving towards scarless operations.

They also explore the role of GLP-1 medications in the medical device market, underlining how pharmaceuticals complement devices in obesity treatment. The episode gives a comprehensive view of Boston Scientific's strategy in integrating Apollo's technology into its portfolio, the challenges of training and adoption, and the optimism for future innovations in minimally invasive procedures.

Thank you to Freudenberg Medical for sponsoring this episode. Please visit Freudenberg Medical’s dedicated webpage at https://www.freudenbergmedical.com/en/single-use-scopes/ to learn more about their specific expertise in this area and to access Freudenberg Medical’s trend paper on the topic.

Thank you for listening to the Boston Scientific Podcast.

Subscribe to this podcast on every major podcast platform, https://linktr.ee/DeviceTalks

Boston Scientific Jones and Dunkin detail why Apollo tech could launch endosurgery revolution

In the latest episode of MedtechWOMEN Talks, Nicole Osmer, Founder & CEO at Health+Commerce, shares her expertise on the role of branding, media relations, and public relations in the medical device product development cycle from the perspective of “The Publicist.”

In the episode, Osmer shares the significance of establishing a strong brand right from a company's inception. Attention to detail in messaging, brand presence, and even the subtleties like an area code on a contact page are pivotal. A central theme revolves around structuring communication effectively through traditional and emerging media channels to make significant market impacts. Osmer's insights on press releases, direct media outreach, and the role of digital platforms offer valuable takeaways on modern medtech marketing. The episode covers not only the 'what' but also the 'how' of successful medtech communications.

TL;DR – Key takeaways:
1. Establishing a strong brand from the early stages and maintaining it throughout the lifecycle of a medtech company is crucial for lasting success.
2. Clear, concise messaging and being prepared for media opportunities with key story elements is essential in PR and branding.
3. Press releases remain a relevant tool for communication, especially when they are concise, impactful, and include a compelling headline.
4. Collaboration across various company functions such as marketing, clinical teams, and investor relations is integral to a coherent communication strategy.

Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support.

https://aptyx.com/ 
https://catalyzehealthcare.com/ 
https://confluentmedical.com/
https://www.cretexmedical.com/

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

How do I get a medical device in front of the right people? with Nicole Osmer

In this week’s episode, Procyrion CEO Eric Fain details the next steps for the startup’s ambitious plans to secure FDA approval for  Aortix, a percutaneous mechanical circulatory support (pMCS) device being developed for patients with acute decompensated heart failure (ADHF) who remain congested despite standard medical therapy (cardiorenal syndrome or CRS). Fain will talk about raising the company’s recent $57.7 million round. He’ll also share some lessons from his successful career as an executive at larger medical device companies. 

In the opening discussion, Co-Hosts Tom Salemi and Chris Newmarker talk with Santosh Iyer, CEO and Founder of Moonshot, a summer program for high school students interested in learning how the Medtech industry uses cool tech to save lives. For more information visit Moonshot.school.

Thanks for listening to the DeviceTalks Weekly Podcast. 

Subscribe to the DeviceTalks Podcast Network.

With $57m secured, CEO Fain Details Next Move for pMCS startup Procyrion; What’s Moonshot’s Mission

This episode of DeviceTalks AI offers a comprehensive look at the ways AI is poised to upend the pharmaceutical industry. It features an in-depth keynote interview with Helen Merianos, Head of Sanofi's R&D Portfolio Strategy, who provides an inside look into Sanofi's commitment to go "all-in" on AI and data science. Merianos discusses the use of Sanofi's proprietary plai app – an AI-enabled smartphone app that draws from over a billion data points – and its role in establishing a data-driven culture across the company.

Additionally, the episode features Michelle Longmire, MD, Co-Founder and CEO of Medable, who discusses the use of generative AI in automating and accelerating clinical trial technology deployment timelines. These applications could cut some timelines in half. Longmire envisions AI's potential to drastically accelerate a development process. “Say there's 10,000 uncured or poorly suboptimally treated human diseases.” At the current pace of drug development, it might take about 200 years to create treatments for those conditions. “Imagine if we could 10x that,” Longmire says.

Join us for the next episode of DeviceTalks AI, where we sit down with Ha Hong, PhD, Chief Artificial Intelligence Officer, Endoscopy at Medtronic.

Thank you to our sponsors Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support.
catalyzehealthcare.com
smarttrak.com

Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH, LISTEN, and READ: https://www.drugdiscoverytrends.com/when-will-drug-development-have-its-chatgpt-moment-inside-ambitious-ai-initiatives-at-sanofi-and-medable/

Thank you for supporting DeviceTalks AI!

Sanofi races to the AI forefront in Big Pharma; Plus, Medable's big promises for clinical trials

In this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an alternative therapy to total hip replacement.

In our main interview, Tom interviews David Wilson, CEO of InnovHeart, a multinational startup that’s developing transcatheter mitral valve replacement systems to treat patients with mitral valve disease. Wilson talks about his journey into medtech, his decision to shift from engineering to sales, and how life as a global president of a medical device business differs from being a start-up CEO.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

InnovHeart CEO Wilson shares vision for TMVR start-up; Our chat with AAOS pitch winner CytexOrtho

In this episode of MedtechWOMEN Talks, Christina Hawley, Sr. Director, of Clinical Operations at May Health helps to unravel the clinical trial process for medical devices, emphasizing the non-linear path from early feasibility to pivotal trials and post-market studies; and delves into the meticulous process of gaining FDA approval and even the nuanced differences between clinical affairs and regulatory affairs.
​
TL;DR – Key takeaways:
- Close collaboration with cross-functional teams, including R&D, regulatory, quality, and marketing, is key to the success of clinical trials.
- Clinical trials must consider the specific regulatory requirements of the targeted geographical markets.
- There is no standardized approach to any of the different clinical trials, each must 

Tune in to gain insights into the complex and surprisingly creative world of clinical research in the medical device industry.

Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!
https://aptyx.com/ 
https://catalyzehealthcare.com/ 
https://confluentmedical.com/
https://www.cretex.com/

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to MedtechWOMEN Talks!

How do I navigate the clinical affairs process effectively? with Christina Hawley, May Health

In this episode of the DeviceTalks Weekly podcast, we meet the 13 finalists for the MedTech Color Pitch Competition, both general and pediatric categories.

Editorial Director Tom Salemi and Managing Editor Kayleen Brown ask each entrepreneur about the problems they’re trying to solve and the solutions they’ve developed. 

Tom and Kayleen also interview MedTech Color’s new executive director, Katrina Holland. The pitch competition takes place March 15.

For the list of finalists and registration information go to MedTechColor.org

Thank you for listening to the DeviceTalks Weekly Podcast.

Please subscribe to the DeviceTalks Podcast Network on any major podcast player.

How MedTech Color’s Pitch Competition Startup Finalists Are Tackling Healthcare’s Biggest Problems

In this episode of Ortho Innovation Talks, Nitin Goyal, MD, chief science, technology and innovation officer at Zimmer Biomet (ZB) shares his journey from the OR to the medtech industry.

Dr. Goyal oversees ZB’s global innovation, medical education, clinical affairs, and reimbursement strategy. He tells host Tom Salemi about his passion for building solutions to address clinical challenges and improve the surgical experience.

Goyal’s own innovations landed him leadership positions at managed care powerhouse, UnitedHealthcare, followed by medtech giant, ZB. Goyal describes how his pursuit of “making an outsized impact” on orthopedic care brought him to ZB, where he leads the global innovation, medical education, and clinical affairs functions.

In this talk, he’ll discuss how ZB incorporates smart implants that track and report mobility data, to big data analytics that guide clinical decision-making throughout the episode of care. Goyal explains why he believes we’re at an inflection point in orthopedics and how ZB intends to lead the way.

Thank you to our season one sponsors, Millstone Medical and AcuityMD, for supporting this podcast. To learn more about our episode sponsor, Millstone Medical, please visit http://millstonemedical.com.

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to the Ortho Innovation Talks podcast!

ZB’s Goyal Explains How Passion for Solving Ortho Challenges Put Him at the Helm of ZB’s R&D Engine

In this episode of the DeviceTalks Weekly podcast, John Murphy, CEO of Virtual Incision, highlights the headline-grabbing surgical robotics start-up. Virtual Incision followed up a trip to the ISS for a nod from the FDA. What’s next? He talks to Editorial Director, Tom Salemi.

But first Shriya Srinivasan, Ph.d, assistant professor at Harvard’s School of Engineering and Applied Sciences, drops some SciFi on Salemi and Chris Newmarker – neuro interfaces, tiny drills that deliver drugs, and much more! Srinivasan will bring her insights to DeviceTalks Boston on May 1!

Thanks to DornerWorks for sponsoring this episode. Find out more at DornerWorks.com.

Thanks for listening to the DeviceTalks Weekly Podcast. 

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

What the spaceMIRA Mission Means for Surgical Robots; Cyborgs, Drill Pills & Other Cool Harvard Tech

In the latest episode of AbbottTalks, Abbott Cardiovascular's leaders, Christopher Piorkowski, MD, DVP and Chief Medical Officer of Electrophysiology, and Dan Kaiser, Divisional VP Product Development, Electrophysiology, delve into the vast landscape of electrophysiology and the comprehensive approach Abbott is taking towards atrial fibrillation (AFib) treatment.

The conversation highlights a potentially innovative pulsed field ablation (PFA) technology and Abbott's broader AFib portfolio, showcasing a commitment to revolutionizing cardiac arrhythmia management. While the Volt™ Pulsed Field Ablation System could represent a significant leap forward with its unique capabilities for creating precise and tissue-selective lesions, Piorkowski and Kaiser emphasize the diversity and depth of solutions Abbott is developing. This includes advancements in diagnostic tools, patient monitoring, and a range of therapeutic approaches designed to offer customized and effective treatment pathways for individuals with AFib.
By focusing on a holistic view of patient care, they discuss how Abbott aims to improve clinical outcomes through technological innovation and enhance patients' quality of life by making treatments more accessible, reducing procedure times, and addressing the broad spectrum of needs within the electrophysiology community. With ongoing clinical trials and research, Abbott is positioned at the forefront of addressing the unmet needs in AFib management, underlining the company's commitment to continuous innovation and patient-centered care.

Thank you to Cretex Medical for sponsoring this episode of AbbottTalks. For more information on how Cretex Medical works with medical device companies, visit www.cretexmedical.com.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott electrophysiology leaders highlight current portfolio, give glimpse of potential PFA device

In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small?

Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career.

To register for the upcoming DeviceTalks Tuesday Surgical Robotics Week or DeviceTalks Boston go to DeviceTalks.com.

Thanks for listening to the DeviceTalks Podcast Network.

Subscribe now to the DeviceTalks Podcast Network on any major podcast player.

How Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics?

In the latest episode of MedtechWOMEN Talks, Rebecca Whitney, SVP, Global Spine President, ZimVie dives deep into what it takes to bring innovative medical solutions to market in a large medtech OEM, weighing the benefits of internal product development against strategic external partnerships.
​
The episode shines a light on the diligent process behind medical device product development, taking into consideration global market nuances, regulatory challenges, and the balance between in-house innovations and external collaborations. Whitney underscores the value of rigorous review stages, which sometimes require difficult decisions like ceasing investment in long-term, costly projects.

Key Takeaways:
- Tough decisions, like halting a project, are necessary for the betterment of patient care and resource allocation.
- Product development incorporates feedback from patients, surgeons, and salesforces to ensure that solutions are practical and market-appropriate.
- Strategic external partnerships can optimize development by leveraging outside expertise, allowing large medtechs like ZimVie to focus on their core strengths.

Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to MedtechWOMEN Talks!

How does the internal medical device development process work at large medtechs?

In this week’s DeviceTalks Weekly Podcast, Bridget C. Bagnato, worldwide president of specimen management at BD, gives us a glimpse of phlebotomy’s future – the BD MiniDraw, a blood testing system that can run a wide array of diagnostic tests on the blood drawn from a fingertip. How might this change how and where blood is drawn in the future.

Thank you to Aptyx for sponsoring this episode! Listen to our interview with CEO Gregg Tobin and go to Aptyx.com for more information.

We also include a portion of an interview Co-Host Tom Salemi did with Nikolai Begg, senior director of portfolio R&D, Robotic Surgical Technologies, Medtronic, in this week’s DeviceTalks Tuesday Surgical Robotics Week. To listen to the entire interview or our other episodes with Intuitive or Virtual Incision go here. https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415884/devicetalks-tuesdays

Also, listen to hear how you can join a unique networking opportunity at Medtronic on April 30 as part of DeviceTalks Boston. We also introduce the new podcast discount code DTWEEKLY25. Use it when you register to attend at DeviceTalks.Boston.com

Thanks for listening to the DeviceTalks Weekly Network.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Can BD’s New MiniDraw System Remove the Pain Points of Blood Testing for Patients, Health Systems

In this week’s DeviceTalks Weekly, Host Tom Salemi thanks the DeviceTalks community for the kindness and support of our podcasts and conferences. He also looks back at our four years and replays Episode 1 where he and Chris Newmarker make some prescient calls on the impact of the pandemic while also showing just how different the world was.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

Four years!? Wow, time flies when you’re talking Medtech. Thank you for listening, DeviceTalkers!

In this week’s DeviceTalks Weekly podcast episode, Host Tom Salemi talks with Joe Mullings of The Mullings Group about the Karl Storz and Asensus Surgical News as well as Johnson & Johnson's big play for Shockwave Medical.

Then, we talk with the leaders of Sovato Health - Yulun Wang, PhD, chairman & co-founder, and Cynthia Perazzo, Co-founder and CEO, about the startup’s plans to build a fiberoptic network to enable remote robotic surgery procedures.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network to catch future episodes.

Can Sovato Health Build Digital Highway for Remote Robotic Surgery? Unpacking the Storz-Asensus News

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives!

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

In this episode of StrykerTalks, Spencer Stiles, Group President of Orthopaedics and Spine at Stryker, discusses Stryker's latest advancements shaping the future of orthopedics and spine care, including an update on the significant role of Mako, Stryker’s pioneering robotic arm-assisted system.

Additionally, Stiles discusses the expansive reach of these innovations, emphasizing their rapid adoption across global markets, particularly in Asia, where Stryker’s advanced solutions meet diverse clinical needs and operational settings. He shares insights into how these technologies cater to the unique challenges faced in different regions, enhancing Stryker's impact on global healthcare landscapes. The conversation further explores Stryker’s strategic growth initiatives, particularly its approach to mergers and acquisitions. Stiles outlines how these moves are carefully crafted to align with Stryker’s long-term vision, ensuring that each acquisition not only expands their market presence but also complements their existing portfolio. 

Thank you to DornerWorks for sponsoring this episode. To learn more about how DornerWorks supports medical device companies, visit www.DornerWorks.com. 

Thank you for listening to the StrykerTalks Podcast.

Subscribe to the DeviceTalks Podcast Network on every major podcast platform.

Spencer Stiles on what's driving Stryker’s ortho growth with surgical robotics and strategic M&A

In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector.

Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. 

Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference!

Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network

Medtronic’s Seidel Maps out Future for Electrophysiology, Pulsed-Field Ablation Portfolio

In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies.

In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders.

TL;DR – Key Takeaways:
- The integration of market insights from the beginning is crucial for successful medical device commercialization.
- Collaborative efforts across various functions are vital to address the comprehensive demands of product development.
- Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively.

Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!

https://aptyx.com/ 
https://catalyzehealthcare.com/ 
https://confluentmedical.com/
https://www.cretex.com/

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

Thank you for listening to MedtechWOMEN Talks!

How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences

In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand.

We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic.

Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders

In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition.

Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations.

Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage.

Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care

In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business.

Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com.

Please subscribe to the DeviceTalks Podcast Network.

Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage

In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD.

This is a replay of the opening keynote interview at DeviceTalks Boston.

This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network.

BD’s CTO Beth McCombs Explains How Medtech Innovation Can Deliver Real Help to Patients, Providers

In this episode of DeviceTalks AI, we are joined by Ha Hong, PhD, Chief Artificial Intelligence Officer of Medtronic Endoscopy about integrating AI into Medtronic's endoscopy unit, the impact on healthcare outcomes, patient-centric design, and the future of AI in the medical device industry. Watch or listen to the episode to:

- Discover how Ha's research coincided with the rise of deep learning, a pivotal technology in modern AI, and how it shaped his work in emulating visual perception processing in the brain.
- Better understand Ha's instrumental role in developing the first FDA-approved AI-powered cardiac ultrasound guidance system, a groundbreaking innovation in cardiology.
- Learn about Ha’s move to Medtronic and his vision for integrating AI into endoscopy, highlighting the potential for AI to revolutionize gastrointestinal diagnostics and treatment.
- Gain insights into Ha's philosophy of patient-centric AI design, emphasizing the importance of prioritizing patient needs and safety in AI development for healthcare.

In the episode, we also sit down with Joe Mish, VP of Sales at SmartTRAK to better understand how SmartTRAK is using AI to enhance their market intelligence solutions, combining the traditional robust analysis with advanced algorithms for more nuanced, speedier insights in the medtech industry.

This conversation comes to you courtesy of our episode sponsor, SmartTRAK. To learn more about SmartTRAK, visit www.smarttrak.com.

Please subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. 

Thank you for listening to DeviceTalks AI!

Medtronic Endoscopy's Chief AI Officer on Transforming Dx through AI and Patient-Centric Design

In this episode of the DeviceTalks Weekly Podcast, we’ll replay our Day 2 opening keynote at DeviceTalks Boston with three senior leaders from CMR Surgical, creator of the versatile Versius surgical robotic systems. 

Co-Founder Mark Slack, MD, now CMO, and Luke Hares, now CTO, identified several problems facing the healthcare system and explained why they saw surgical robotics as the solution. Longtime Medical Device Leader Supratim Bose, now CEO of the company, lends his insights in how Versius can fill a huge need for healthcare systems and hospitals. 

This episode is sponsored by Qt Group. Listen to understand how they can help your medical device development or go to Qt.io for more information.

Thank you for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network to listen to future episodes of this and our family of medical device podcasts.

DeviceTalks.com

Transforming surgery with Versius: bringing robotic assisted surgery to patients worldwide

The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 10 podcasts:

• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• DeviceTalks Weekly
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

Popular tracks by DeviceTalks